Marco Miceli

2.1k total citations
54 papers, 1.5k citations indexed

About

Marco Miceli is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Marco Miceli has authored 54 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 7 papers in Oncology and 6 papers in Surgery. Recurrent topics in Marco Miceli's work include Histone Deacetylase Inhibitors Research (17 papers), Epigenetics and DNA Methylation (13 papers) and Protein Degradation and Inhibitors (11 papers). Marco Miceli is often cited by papers focused on Histone Deacetylase Inhibitors Research (17 papers), Epigenetics and DNA Methylation (13 papers) and Protein Degradation and Inhibitors (11 papers). Marco Miceli collaborates with scholars based in Italy, United States and Austria. Marco Miceli's co-authors include Lucia Altucci, Angela Nebbioso, Antonello Mai, Dante Rotili, Sérgio Valente, Gianluca Sbardella, Gerald Brosch, Flavia Franconi, Giuseppe Seghieri and Roberto Anichini and has published in prestigious journals such as The Journal of Immunology, American Journal of Clinical Nutrition and International Journal of Molecular Sciences.

In The Last Decade

Marco Miceli

44 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marco Miceli Italy 24 836 277 145 143 123 54 1.5k
Lawrence M. Szewczuk United States 15 860 1.0× 152 0.5× 127 0.9× 106 0.7× 79 0.6× 20 1.2k
Shifeng Pan China 20 1.0k 1.2× 419 1.5× 216 1.5× 104 0.7× 246 2.0× 67 1.8k
Mohamed Ouzzine France 26 916 1.1× 217 0.8× 280 1.9× 459 3.2× 74 0.6× 64 1.7k
Jinghua Yu China 22 764 0.9× 141 0.5× 593 4.1× 163 1.1× 113 0.9× 75 1.7k
Yoshihiko Noguchi Japan 20 732 0.9× 151 0.5× 246 1.7× 94 0.7× 100 0.8× 61 1.4k
Julian C. Desmond United States 18 1.0k 1.2× 64 0.2× 260 1.8× 205 1.4× 75 0.6× 25 1.7k
Andréia Machado Leopoldino Brazil 23 989 1.2× 98 0.4× 262 1.8× 108 0.8× 77 0.6× 79 1.5k
Saori Takahashi Japan 23 1.1k 1.3× 57 0.2× 116 0.8× 81 0.6× 129 1.0× 75 1.7k
Constantin Tamvakopoulos Greece 21 692 0.8× 108 0.4× 275 1.9× 69 0.5× 90 0.7× 56 1.5k
John T. Dulaney United States 19 928 1.1× 192 0.7× 127 0.9× 239 1.7× 369 3.0× 34 1.5k

Countries citing papers authored by Marco Miceli

Since Specialization
Citations

This map shows the geographic impact of Marco Miceli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marco Miceli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marco Miceli more than expected).

Fields of papers citing papers by Marco Miceli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marco Miceli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marco Miceli. The network helps show where Marco Miceli may publish in the future.

Co-authorship network of co-authors of Marco Miceli

This figure shows the co-authorship network connecting the top 25 collaborators of Marco Miceli. A scholar is included among the top collaborators of Marco Miceli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marco Miceli. Marco Miceli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sarno, Laura, Stefano Raffaele Giannubilo, Andrea Ciavattini, et al.. (2025). Fetal heart rate variability and monitoring in gestational diabetes mellitus: a narrative review. The Journal of Maternal-Fetal & Neonatal Medicine. 38(1). 2576484–2576484.
2.
Cevenini, Armando, Pasqualino De Antonellis, Laura Letizia Mazzarelli, et al.. (2025). Lytic or Latent Phase in Human Cytomegalovirus Infection: An Epigenetic Trigger. International Journal of Molecular Sciences. 26(23). 11554–11554.
4.
Donati, Danilo, Roberto Tedeschi, Francesco Castagnini, et al.. (2024). The Effectiveness of Ultrasound-Guided Infiltrations Combined with Early Rehabilitation in the Management of Low Back Pain: A Retrospective Observational Study. Diagnostics. 14(18). 2087–2087.
6.
Ferrucci, Veronica, Marco Miceli, Chiara Pagliuca, et al.. (2024). Modulation of innate immunity related genes resulting in prophylactic antimicrobial and antiviral properties. Journal of Translational Medicine. 22(1). 574–574. 3 indexed citations
7.
Girolamo, Raffaella Di, F. D’Antonio, Antonio Raffone, et al.. (2023). Do Anti-SARS-CoV-2 Monoclonal Antibodies Have an Impact on Pregnancy Outcome? A Systematic Review and Meta-Analysis. Vaccines. 11(2). 344–344. 3 indexed citations
9.
Mazzotti, Antonio, et al.. (2022). Iatrogenic Lesion of the Lateral Plantar Artery following Plantar Fasciotomy for Cavus Foot Correction – A Case Report. Journal of Orthopaedic Case Reports. 12(10). 10–13.
10.
Pepin, Mark E., Concetta Schiano, Marco Miceli, et al.. (2021). The human aortic endothelium undergoes dose-dependent DNA methylation in response to transient hyperglycemia. Experimental Cell Research. 400(2). 112485–112485. 31 indexed citations
11.
Miceli, Marco, Adele Cutignano, Mariarosaria Conte, et al.. (2019). Monoacylglycerides from the Diatom Skeletonema marinoi Induce Selective Cell Death in Cancer Cells. Marine Drugs. 17(11). 625–625. 23 indexed citations
12.
Miceli, Marco, et al.. (2019). Peripheral artery disease: the new frontiers of imaging techniques to evaluate the evolution of regenerative medicine. Expert Review of Cardiovascular Therapy. 17(7). 511–532. 8 indexed citations
13.
Crescenzo, Agostina De, Angela Sparago, Flavia Cerrato, et al.. (2012). Paternal deletion of the 11p15.5 centromeric-imprinting control region is associated with alteration of imprinted gene expression and recurrent severe intrauterine growth restriction. Journal of Medical Genetics. 50(2). 99–103. 33 indexed citations
14.
Carafa, Vincenzo, Marco Miceli, Lucia Altucci, & Angela Nebbioso. (2012). Histone deacetylase inhibitors: a patent review (2009 – 2011). Expert Opinion on Therapeutic Patents. 23(1). 1–17. 33 indexed citations
15.
Nebbioso, Angela, Raquel Pereira, Harshal Khanwalkar, et al.. (2011). Death Receptor Pathway Activation and Increase of ROS Production by the Triple Epigenetic Inhibitor UVI5008. Molecular Cancer Therapeutics. 10(12). 2394–2404. 46 indexed citations
16.
Valente, Sérgio, Maria Tardugno, Mariarosaria Conte, et al.. (2011). Novel Cinnamyl Hydroxyamides and 2‐Aminoanilides as Histone Deacetylase Inhibitors: Apoptotic Induction and Cytodifferentiation Activity. ChemMedChem. 6(4). 698–712. 18 indexed citations
17.
Souto, José A., Rosaria Benedetti, Katharina A. Otto, et al.. (2010). New Anacardic Acid‐Inspired Benzamides: Histone Lysine Acetyltransferase Activators. ChemMedChem. 5(9). 1530–1540. 14 indexed citations
18.
Bernardo, Giovanni Di, Tiziana Squillaro, Carmela Dell’Aversana, et al.. (2008). Histone Deacetylase Inhibitors Promote Apoptosis and Senescence in Human Mesenchymal Stem Cells. Stem Cells and Development. 18(4). 573–582. 50 indexed citations
19.
Mai, Antonello, Sérgio Valente, Dante Rotili, et al.. (2007). Novel pyrrole-containing histone deacetylase inhibitors endowed with cytodifferentiation activity. The International Journal of Biochemistry & Cell Biology. 39(7-8). 1510–1522. 13 indexed citations
20.
Simplicio, Paolo Di, Elena Cardaioli, Marco Miceli, et al.. (1995). Glutathione, glutathione utilizing enzymes and thioltransferase in platelets of insulin‐dependent diabetic patients: relation with platelet aggregation and with microangiopatic complications. European Journal of Clinical Investigation. 25(9). 665–669. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026